CORC

浏览/检索结果: 共7条,第1-7条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Genome-wide analysis of gene expression profile in the respiratory tree of sea cucumber (Apostichopus japonicus) in response to hypoxia conditions 期刊论文
JOURNAL OF THE MARINE BIOLOGICAL ASSOCIATION OF THE UNITED KINGDOM, 2018, 卷号: 98, 期号: 8, 页码: 2039-2048
作者:  Zhang, Libin;  Feng, Qiming;  Ding, Kui;  Sun, Lina;  Huo, Da
收藏  |  浏览/下载:30/0  |  提交时间:2019/07/15
Differential gene expression in the body wall of the sea cucumber (Apostichopus japonicus) under strong lighting and dark conditions 期刊论文
ACTA OCEANOLOGICA SINICA, 2018, 卷号: 37, 期号: 5, 页码: 54-66
作者:  Zhang Libin;  Feng Qiming;  Sun Lina;  Fang Yan;  Xu Dongxue
收藏  |  浏览/下载:21/0  |  提交时间:2019/07/15
Differential gene expression in the intestine of sea cucumber (Apostichopus japonicus) under low and high salinity conditions 期刊论文
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY D-GENOMICS & PROTEOMICS, 2018, 卷号: 25, 页码: 34-41
作者:  Zhang, Libin;  Feng, Qiming;  Sun, Lina;  Ding, Kui;  Huo, Da
收藏  |  浏览/下载:16/0  |  提交时间:2019/07/15
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 11
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/04
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. 期刊论文
JAMA Oncology, 2018, 卷号: 4, 期号: 11, 页码: 1569-1575
作者:  Han, Baohui*;  Li, Kai*;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/03
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. 期刊论文
JAMA oncology, 2018, 卷号: 4, 页码: 1569-1575
作者:  Han Baohui;  Li Kai;  Wang Qiming;  Zhang Li;  Shi Jianhua
收藏  |  浏览/下载:5/0  |  提交时间:2019/11/26
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
2018, 卷号: 4, 期号: 11, 页码: 1569-1575
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace